PREECLAMPSIA: FROM EMERGENCY CARE TO STAGES OF REHABILITATION
Keywords:
preeclampsia, eclampsia, magnesium sulfate, postpartum follow-up, cardiovascular risk, chronic kidney disease, obstetric rehabilitation.Abstract
Objective. To summarize current evidence on the diagnosis of preeclampsia, principles of emergency care, obstetric management, and postpartum rehabilitation, with emphasis on long-term cardiovascular and renal prevention. Materials and methods. A narrative review of current international guidance and analytical publications was performed, including recommendations from the American College of Obstetricians and Gynecologists (ACOG), the National Institute for Health and Care Excellence (NICE), the World Health Organization (WHO), and recent reviews on postpartum care and long-term cardiovascular and renal outcomes after preeclampsia. Results. Preeclampsia remains one of the leading causes of maternal and perinatal morbidity and mortality worldwide. Contemporary management requires early recognition of the disease, timely administration of magnesium sulfate for seizure prophylaxis and treatment, prompt control of severe hypertension, continuous assessment of maternal and fetal status, and determination of the optimal timing of delivery. Postpartum care should not end with hospital discharge. Women with a history of preeclampsia require blood pressure monitoring, laboratory reassessment, evaluation of renal function, and subsequent referral for long-term cardiometabolic risk reduction. Conclusion. Preeclampsia should be regarded not only as an acute obstetric complication but also as a marker of future cardiovascular and renal disease. Effective care is based on a continuum that starts with emergency stabilization and timely delivery and continues through structured postpartum follow-up, long-term prevention, and preconception counseling before future pregnancies.
References
1. American College of Obstetricians and Gynecologists. Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin No. 222. Washington, DC: ACOG; 2020.
2. National Institute for Health and Care Excellence. Hypertension in Pregnancy: Diagnosis and Management. NICE Guideline NG133. London: NICE; 2019. Updated review 2023.
3. World Health Organization. WHO Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia. Geneva: WHO; 2011.
4. World Health Organization. WHO Recommendations on Antiplatelet Agents for the Prevention of Pre-eclampsia. Geneva: WHO; 2021.
5. World Health Organization. WHO Recommendation: Calcium Supplementation During Pregnancy for the Prevention of Pre-eclampsia and Its Complications. Geneva: WHO; 2018.
6. Lewey J, et al. Opportunities in the Postpartum Period to Reduce Cardiovascular Disease Risk Following Adverse Pregnancy Outcomes. Circulation. 2024.
7. Palatnik A, et al. Postpartum Management of Hypertensive Disorders of Pregnancy. American Journal of Obstetrics and Gynecology. 2024.
8. Haudiquet M, et al. A Systematic Review on the Determinants of Long-Term Kidney Sequelae After Preeclampsia. Acta Obstetricia et Gynecologica Scandinavica. 2025.

